Mosapride is a gastrointestinal prokinetic agent, this drug should not be combined with anticholinergics (e.g., atropine sulfate, butylscopolamine bromide, etc.), otherwise the effect of this drug may be attenuated. Mosapride is a selective 5-hydroxytryptamine receptor agonist, which plays the role of promoting digestion by promoting the release of acetylcholine and stimulating the gastrointestinal tract, and can improve the gastrointestinal symptoms of patients with functional dyspepsia without affecting the secretion of gastric acid. It is mainly used for the treatment of functional dyspepsia, gastroesophageal reflux disease and gastric dysfunction in patients with partial gastrectomy. Adverse reactions to the drug include diarrhea, abdominal pain, dry mouth, dizziness, palpitations (rapid heartbeat, often accompanied by panic). It should be noted that the drug is contraindicated in people who are allergic to the drug, people with bleeding and perforation of the gastrointestinal tract and patients with intestinal obstruction. The above medications need to be used under the supervision of a doctor and avoid self-medication.